胃主細胞cholecystokinin受容体特性に関する研究 I  CCK類似体及び各種CCK受容体きっ抗剤のペプシノーゲン分泌反応及び主細胞内Ca`2+´濃度に及ぼす効果

書誌事項

タイトル別名
  • Characterization of cholecystokinin receptors in gastric chief cells - Effect of CCK analogs and CCK receptor antagonists on chief cells.
  • Effect of CCK analogs and CCK receptor antagonists on chief cells
  • -第1報-CCK類似体及び各種CCK受容体拮抗剤のペプシノーゲン分泌反応及び主細胞内Ca<sup>2+</sup>濃度に及ぼす効果

抄録

In isolated guinea pig gastric chief cells, gatrin-I and cholecystokinin-hexapeptide (CCK-4) stimulated pepsinogen release. However, the efficacies of these two peptide were 51% of that observed with CCK-octapeptide (CCK8). CR1409 and L-364718, both of which are new CCK receptor antagonists in pancreatic acinar cells, also inhibited 10-8M CCK8-stimulated pepsinogen release with a half-maximal inhibitory concentration (IC50) observed at 3×10-9M, respectively. The dose response curve to CCK8 for pepsinogen release shifted to the right in the presence of CR1409 or, L-364718. The IC50 of these two antagonists for the CCK8-stimulated increase in cytosolic Ca2+ concentration monitored by Fura-2 were equal to those for CCK8-stimulated pepsinogen release. By contrast, the IC50 of dibutyryl cyclic GMP, a well-known CCK receptor antagonist, for CCK8-stimulated pepsinogen release was less than that for CCK8-stimulated increase in cytosolic Ca2+ concentration. Results suggested that CCK receptors in gastric chief cells are unique and may be different from CCK receptors in other tissues previously repoted.

収録刊行物

詳細情報 詳細情報について

  • CRID
    1390282681374959616
  • NII論文ID
    130001067264
  • DOI
    10.11405/nisshoshi1964.86.1424
  • COI
    1:STN:280:DyaK3c%2FktFGjtg%3D%3D
  • ISSN
    13497693
    04466586
  • PubMed
    2810848
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ